{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:12:27Z","timestamp":1784650347825,"version":"3.55.0"},"reference-count":58,"publisher":"Bioscientifica","issue":"11","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,1]]},"abstract":"<jats:p>The CUT\/Hox transcription factor ONECUT2 (OC2) promotes lineage plasticity and is a confirmed therapeutic target in prostate cancer and several other malignancies where cell phenotype plays a substantial role in treatment resistance. OC2 governs a broad growth and lineage identity process in prostate cancer that promotes neuroendocrine (NE) differentiation, androgen receptor (AR) suppression, and the emergence of a wide range of treatment-resistant pathways. The mode of action of OC2 includes incorporation of the protein into transcription complexes at gene promoters as an activator and repressor, alteration of chromatin accessibility and epigenetic marks, and extensive alteration of large-scale chromatin modifications, such as super-enhancers and chromatin loops. Notably, OC2 may be unique among NE drivers in that it can promote AR indifference in adenocarcinoma as a direct upstream activator of the glucocorticoid receptor, thus assuming indirect control of a portion of the AR cistrome. OC2 expression and activity increase substantially following hormone therapy in association with aggressive disease in prostate and breast cancer. Experiments in model systems have shown that OC2 has a survival function in both human castration-sensitive and castration-resistant prostate cancer cells. OC2 can be targeted directly with a family of novel small-molecule inhibitors that show therapeutic efficacy in vivo in prostate, breast, and gastric cancer models, including regression of established distant metastases in mice. These findings suggest that inhibition of OC2 clinically may confer substantial therapeutic benefit in some aggressive malignancies, including in localized hormone-sensitive disease.<\/jats:p>","DOI":"10.1530\/erc-25-0272","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T12:41:08Z","timestamp":1762951268000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":1,"title":["ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignancies"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-3432","authenticated-orcid":false,"given":"Michael R","family":"Freeman","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-6541","authenticated-orcid":true,"given":"Lillian M","family":"Perez","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qian","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran","family":"Murali","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirja","family":"Rotinen","sequence":"additional","affiliation":[{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin M","family":"Posadas","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Di Vizio","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"},{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Freedland","sequence":"additional","affiliation":[{"name":"1"},{"name":"8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-1783","authenticated-orcid":true,"given":"Sungyong","family":"You","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"},{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2026070909434746300_bib1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026070909434746300_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamaoncol.2020.6973","article-title":"Comparison of systemic treatments for metastatic castration-sensitive prostate cancer: a systematic review and network meta-analysis","volume":"7","author":"Wang","year":"2021","journal-title":"JAMA Oncol"},{"key":"2026070909434746300_bib3","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026070909434746300_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178604","article-title":"Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer","volume":"134","author":"Zhu","year":"2024","journal-title":"J Clin Investig"},{"key":"2026070909434746300_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","article-title":"Lineage plasticity in cancer: a shared pathway of therapeutic resistance","volume":"17","author":"Quintanal-Villalonga","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2026070909434746300_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","article-title":"Resistance to second-generation androgen receptor antagonists in prostate cancer","volume":"18","author":"Schmidt","year":"2021","journal-title":"Nat Rev Urol"},{"key":"2026070909434746300_bib7","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1158\/1078-0432.CCR-12-3791","article-title":"Platinum-based chemotherapy for variant castrate-resistant prostate cancer","volume":"19","author":"Aparicio","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2026070909434746300_bib8","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/1078-0432.CCR-13-3309","article-title":"Aggressive variants of castration-resistant prostate cancer","volume":"20","author":"Beltran","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2026070909434746300_bib9","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026070909434746300_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1903307","article-title":"Apalutamide for metastatic, castration-sensitive prostate cancer","volume":"381","author":"Chi","year":"2019","journal-title":"N Engl J Med"},{"key":"2026070909434746300_bib11","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1200\/JCO.22.00193","article-title":"Improved survival with enzalutamide in patients with metastatic hormone-sensitive prostate cancer","volume":"40","author":"Armstrong","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026070909434746300_bib12","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved outcomes with enzalutamide in biochemically recurrent prostate cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"2026070909434746300_bib13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","article-title":"ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis","volume":"24","author":"Rotinen","year":"2018","journal-title":"Nat Med"},{"key":"2026070909434746300_bib14","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1158\/0008-5472.CAN-16-0902","article-title":"Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome","volume":"76","author":"You","year":"2016","journal-title":"Cancer Res"},{"key":"2026070909434746300_bib15","doi-asserted-by":"crossref","first-page":"D103","DOI":"10.1093\/nar\/gki004","article-title":"TRED: a transcriptional regulatory element database and a platform for in silico gene regulation studies","volume":"33","author":"Zhao","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2026070909434746300_bib16","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","article-title":"ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments","volume":"26","author":"Lachmann","year":"2010","journal-title":"Bioinformatics"},{"key":"2026070909434746300_bib17","doi-asserted-by":"crossref","first-page":"D177","DOI":"10.1093\/nar\/gks1060","article-title":"ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026070909434746300_bib18","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1074\/jbc.274.5.2665","article-title":"OC-2, a novel mammalian member of the ONECUT class of homeodomain transcription factors whose function in liver partially overlaps with that of hepatocyte nuclear factor-6","volume":"274","author":"Jacquemin","year":"1999","journal-title":"J Biol Chem"},{"key":"2026070909434746300_bib19","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1101\/gad.340305","article-title":"Control of liver cell fate decision by a gradient of TGF beta signaling modulated by onecut transcription factors","volume":"19","author":"Clotman","year":"2005","journal-title":"Genes Dev"},{"key":"2026070909434746300_bib20","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ydbio.2007.02.027","article-title":"Role of the onecut transcription factors in pancreas morphogenesis and in pancreatic and enteric endocrine differentiation","volume":"305","author":"Vanhorenbeeck","year":"2007","journal-title":"Dev Biol"},{"key":"2026070909434746300_bib21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuron.2007.07.010","article-title":"Retrograde BMP signaling regulates trigeminal sensory neuron identities and the formation of precise face maps","volume":"55","author":"Hodge","year":"2007","journal-title":"Neuron"},{"key":"2026070909434746300_bib22","doi-asserted-by":"crossref","first-page":"8631","DOI":"10.1038\/s41467-024-52762-z","article-title":"Concerted transcriptional regulation of the morphogenesis of hypothalamic neurons by ONECUT3","volume":"15","author":"Zupan\u010di\u010d","year":"2024","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.cub.2022.02.040","article-title":"Robust regulatory architecture of pan-neuronal gene expression","volume":"32","author":"Leyva-D\u00edaz","year":"2022","journal-title":"Curr Biol"},{"key":"2026070909434746300_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physiolgenomics.00017.2010","article-title":"Onecut-2 knockout mice fail to thrive during early postnatal period and have altered patterns of gene expression in small intestine","volume":"42","author":"Dusing","year":"2010","journal-title":"Physiol Genomics"},{"key":"2026070909434746300_bib25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/labinvest.2008.168","article-title":"PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription","volume":"89","author":"Kanteti","year":"2009","journal-title":"Lab Invest"},{"key":"2026070909434746300_bib26","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.5858\/2009-0664-OAR1.1","article-title":"Expression patterns of PAX5, c-Met, and paxillin in neuroendocrine tumors of the lung","volume":"134","author":"Song","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2026070909434746300_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s41419-024-06916-y","article-title":"Understanding the function of Pax5 in development of docetaxel-resistant neuroendocrine-like prostate cancers","volume":"15","author":"Bhattacharya","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026070909434746300_bib28","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/elps.200700093","article-title":"Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods","volume":"28","author":"Yamamoto","year":"2007","journal-title":"Electrophoresis"},{"key":"2026070909434746300_bib29","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1158\/1078-0432.CCR-14-3334","article-title":"Identification of a candidate gene panel for the early diagnosis of prostate cancer","volume":"21","author":"Leyten","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026070909434746300_bib30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ng.3637","article-title":"Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer","volume":"48","author":"Guo","year":"2016","journal-title":"Nat Genet"},{"key":"2026070909434746300_bib31","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026070909434746300_bib32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"2026070909434746300_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41467-018-08133-6","article-title":"ONECUT2 is a driver of neuroendocrine prostate cancer","volume":"10","author":"Guo","year":"2019","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1206259","article-title":"Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3\u2032 untranslated region","volume":"11","author":"Steadman","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"2026070909434746300_bib35","doi-asserted-by":"crossref","first-page":"2860582","DOI":"10.1155\/2020\/2860582","article-title":"Construction of ceRNA coexpression network and screening of molecular targets in colorectal cancer","volume":"2020","author":"Hui","year":"2020","journal-title":"Dis Markers"},{"key":"2026070909434746300_bib36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"2026070909434746300_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/1078-0432.CCR-17-0989","article-title":"The glucocorticoid receptor is a key player for prostate cancer cell survival and a target for improved antiandrogen therapy","volume":"24","author":"Puhr","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026070909434746300_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/nar\/gkad1126","article-title":"Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer","volume":"52","author":"Helminen","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026070909434746300_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s10020-025-01267-6","article-title":"ONECUT2 reprograms neuroendocrine fate and is an actionable therapeutic target in small cell lung cancer","volume":"31","author":"Guti\u00e9rrez","year":"2025","journal-title":"Mol Med"},{"key":"2026070909434746300_bib40","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.celrep.2015.07.012","article-title":"The placental gene PEG10 promotes progression of neuroendocrine prostate cancer","volume":"12","author":"Akamatsu","year":"2015","journal-title":"Cell Rep"},{"key":"2026070909434746300_bib41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/nar\/gkac1236","article-title":"ONECUT2 regulates RANKL-dependent enterocyte and microfold cell differentiation in the small intestine; a multi-omics study","volume":"51","author":"Luna Velez","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2026070909434746300_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13402-024-00957-3","article-title":"ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity","volume":"48","author":"Zamora","year":"2025","journal-title":"Cell Oncol"},{"key":"2026070909434746300_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101200","article-title":"YTHDF2-mediated m6A modification of ONECUT2 promotes stemness and oxaliplatin resistance in gastric cancer through transcriptionally activating TFPI","volume":"79","author":"Fan","year":"2025","journal-title":"Drug Resist Updat"},{"key":"2026070909434746300_bib44","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1038\/s41467-024-53159-8","article-title":"The homeodomain regulates stable DNA binding of prostate cancer target ONECUT2","volume":"15","author":"Chatterjee","year":"2024","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib45","first-page":"397","article-title":"Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer","volume":"10","author":"Qian","year":"2022","journal-title":"Am J Clin Exp Urol"},{"key":"2026070909434746300_bib46","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/ijc.32946","article-title":"ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5","volume":"146","author":"Seo","year":"2020","journal-title":"Int J Cancer"},{"key":"2026070909434746300_bib47","first-page":"9378","article-title":"Up-regulated ONECUT2 and down-regulated SST promote gastric cell migration, invasion, epithelial-mesenchymal transition and tumor growth in gastric cancer","volume":"24","author":"Wang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026070909434746300_bib48","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1177\/15353702211038496","article-title":"ONECUT2 which is targeted by hsa-miR-15a-5p enhances stemness maintenance of gastric cancer stem cells","volume":"246","author":"Shen","year":"2021","journal-title":"Exp Biol Med"},{"key":"2026070909434746300_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41419-024-06885-2","article-title":"Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via an AKT-related pathway","volume":"15","author":"Lin","year":"2024","journal-title":"Cell Death Dis"},{"key":"2026070909434746300_bib50","doi-asserted-by":"crossref","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"key":"2026070909434746300_bib52","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1038\/s41467-024-46057-6","article-title":"Neuronal miR-9 promotes HSV-1 epigenetic silencing and latency by repressing Oct-1 and onecut family genes","volume":"15","author":"Deng","year":"2024","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112840","article-title":"Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3\u2032 untranslated region mutations","volume":"42","author":"Schuster","year":"2023","journal-title":"Cell Rep"},{"key":"2026070909434746300_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026070909434746300_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1331355","article-title":"Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours","volume":"14","author":"Bigos","year":"2024","journal-title":"Front Oncol"},{"key":"2026070909434746300_bib56","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41467-019-09649-1","article-title":"Competitive endogenous RNA is an intrinsic component of EMT regulatory circuits and modulates EMT","volume":"10","author":"Liu","year":"2019","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"2026070909434746300_bib58","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1038\/s41467-021-26840-5","article-title":"Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression","volume":"12","author":"Bolis","year":"2021","journal-title":"Nat Commun"},{"key":"2026070909434746300_bib59","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-23-2438","article-title":"Integrative molecular analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) series","volume":"30","author":"Anselmino","year":"2024","journal-title":"Clin Cancer Res"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/11\/ERC-25-0272.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/11\/ERC-25-0272.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0272\/505606\/erc-25-0272.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0272\/505606\/erc-25-0272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:43:59Z","timestamp":1783604639000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/11\/e250272\/75478\/ONECUT2-a-validated-drug-target-and-lineage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0272","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"e250272"}}